AbbVie Presents Late-Breaking Atogepant Phase 3 Results for Episodic Migraine Treatment at 2023 AAN Meeting.

The Phase 3 ELEVATE study demonstrated atogepant is effective and well-tolerated for the preventive treatment of episodic migraine in people who previous...

April 21, 2023 | Friday | News
CDC Reports First-Ever Profound Autism Prevalence Data

The Centers for Disease Control and Prevention today reported 26.7 percent of people with autism spectrum disorder have "profound autism". It is the first ...

April 20, 2023 | Thursday | News
JACS Solutions and Baicells to Unveil End-to-End Private 5G Solutions for the Healthcare Industry

Baicells Technologies, a global provider of LTE and 5G network solutions, and JACS Solutions, a global provider of custom connectivity solutions for indust...

April 20, 2023 | Thursday | News
Segmed, NVIDIA, and RadImageNet Kickstart Generative AI Initiative for Synthetic Medical Imaging Data

As part of this initiative, Segmed will offer synthetic medical imaging data on their self-serve medical data curation platform, Segmed Insight. This is in...

April 20, 2023 | Thursday | News
PANTHERx® Rare Announces Release of CUVRIOR™ to Treat Wilson Disease

"We are pleased to add CUVRIOR to the list of PANTHERx® medications. The PANTHERx team works hard to make a positive difference in the lives of ou...

April 20, 2023 | Thursday | News
Takeda Showcases Digital Health Solutions at G20 Meeting in India

Takeda Biopharmaceuticals India Private Limited Showcased Digital Innovations- MyPKFit, SYNAPSE and Athena at the G20 Health Working Group Meeting ·...

April 19, 2023 | Wednesday | News
Cali Biosciences Begins Phase III Study of Long-Acting Ropivacaine for Pain Reduction After Surgery

Cali Biosciences Co., Ltd. (hereinafter referred to as "Cali" or "Cali Biosciences"), a biopharmaceutical company focused on the research and development o...

April 19, 2023 | Wednesday | News
Shionogi Shows Fetcroja Efficacy Against Tough Gram-Negative Bacteria in Real-World Evidence

Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") announces key data for Fetcroja&...

April 18, 2023 | Tuesday | News
Avenue Therapeutics Announces Regulatory Update Based on Type C Meeting with FDA and Next Steps in the Development of IV Tramadol

As disclosed in September 2022, Avenue received meeting minutes from the FDA regarding a Type A meeting conducted on August 9, 2022, for IV Tramadol. At th...

April 18, 2023 | Tuesday | News
Imprivata Launches Healthcare Digital Identity Maturity Model and Assessment

Imprivata, the digital identity company for life-and mission-critical industries,  announced the launch of the Imprivata Digital Identity Maturity Mod...

April 17, 2023 | Monday | News
Alpro Pharmacy Increases Order Fulfilment Efficiency by 80% with Zebra Technologies’ Solutions

 Zebra Technologies Corporation (NASDAQ: ZBRA), an innovator at the front  line of business with solutions and partners that deliver a performanc...

April 17, 2023 | Monday | News
Daon to Bring Trusted Identity Proofing and Authentication Solutions to Healthcare Industry

Daon, the Digital Identity Trust company, is expanding its identity proofing and authentication solutions to the healthcare industry to enable organization...

April 14, 2023 | Friday | News
From tragedy, a potential pediatric cancer treatment

Cold Spring Harbor Laboratory Professor Adrian Krainer is best known for his groundbreaking research on antisense oligonucleotides (ASOs)—m...

April 13, 2023 | Thursday | News
GC Genome shows Liquid Biopsy Technology can predict response to Radiation Therapy in Solid Tumors

The research was in collaboration with the Samsung Medical Center, Sungkyunkwan University School of Medicine. This study adds to the previous studies of p...

April 10, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close